Valiant Laboratories Limited (VALIANTLAB.NS)
INR 82.64
(0.33%)
INR 82.64
(0.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.42 Billion INR | 60.91% |
| 2022 | 2.12 Billion INR | 17.14% |
| 2021 | 1.81 Billion INR | 71.01% |
| 2020 | 1.06 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q4 | 3.42 Billion INR | 0.0% |
| 2023 FY | 3.42 Billion INR | 60.91% |
| 2023 Q2 | 2.15 Billion INR | -2.25% |
| 2023 Q1 | 2.2 Billion INR | 3.35% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q4 | 2.12 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -12.359% |
| Aarti Drugs Limited | 24.32 Billion INR | 85.911% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 86.728% |
| Ajanta Pharma Limited | 46.38 Billion INR | 92.612% |
| Alembic Limited | 23.28 Billion INR | 85.285% |
| Alkem Laboratories Limited | 155.74 Billion INR | 97.8% |
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 94.683% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | 68.212% |
| Bal Pharma Limited | 3.2 Billion INR | -6.96% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -627.841% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | 71.769% |
| Brooks Laboratories Limited | 904.45 Million INR | -278.889% |
| Bafna Pharmaceuticals Limited | 1.47 Billion INR | -132.045% |
| Caplin Point Laboratories Limited | 26.97 Billion INR | 87.296% |
| Divi's Laboratories Limited | 154.7 Billion INR | 97.785% |
| Eris Lifesciences Limited | 70.48 Billion INR | 95.138% |
| Granules India Limited | 55.2 Billion INR | 93.793% |
| Ind-Swift Limited | 6.54 Billion INR | 47.639% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -57.864% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 91.42% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 97.033% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -42.75% |
| Medicamen Biotech Limited | 2.94 Billion INR | -16.354% |
| Medico Remedies Limited | 961.95 Million INR | -256.241% |
| Wockhardt Limited | 76.49 Billion INR | 95.52% |
| Orchid Pharma Limited | 15.53 Billion INR | 77.946% |
| RPG Life Sciences Limited | 5.12 Billion INR | 33.182% |
| Shilpa Medicare Limited | 30.93 Billion INR | 88.921% |
| Sigachi Industries Limited | 6.94 Billion INR | 50.633% |
| Solara Active Pharma Sciences Limited | 23.46 Billion INR | 85.396% |
| Unichem Laboratories Limited | 31.69 Billion INR | 89.187% |
| Vaishali Pharma Limited | 799.55 Million INR | -328.596% |
| Wanbury Limited | 3.43 Billion INR | 0.235% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 98.83% |
| FDC Limited | 24.68 Billion INR | 86.115% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | 6.592% |
| Bajaj HealthCare Limited | 7.65 Billion INR | 55.212% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.116% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 87.978% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | 70.587% |
| Laurus Labs Limited | 83.87 Billion INR | 95.914% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -2.778% |
| Nectar Lifesciences Limited | 21.91 Billion INR | 84.36% |
| Par Drugs and Chemicals Limited | 1.01 Billion INR | -237.254% |
| Hester Biosciences Limited | 6.62 Billion INR | 48.262% |
| Ipca Laboratories Limited | 111.01 Billion INR | 96.913% |
| Venus Remedies Limited | 6.26 Billion INR | 45.33% |
| ZIM Laboratories Limited | 4.46 Billion INR | 23.306% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 99.24% |
| Morepen Laboratories Limited | 12.93 Billion INR | 73.501% |
| Neuland Laboratories Limited | 18.32 Billion INR | 81.3% |
| Sequent Scientific Limited | 15.4 Billion INR | 77.753% |
| Suven Pharmaceuticals Limited | 22.54 Billion INR | 84.797% |
| Windlas Biotech Limited | 6.26 Billion INR | 45.276% |
| Hikal Limited | 24.87 Billion INR | 86.222% |
| Innova Captab Limited | 13.2 Billion INR | 74.056% |
| Procter & Gamble Health Limited | 7.94 Billion INR | 56.86% |
| Themis Medicare Limited | 5.66 Billion INR | 39.499% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 84.731% |
| Mankind Pharma Limited | 119.63 Billion INR | 97.136% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 97.613% |
| Sakar Healthcare Limited | 3.88 Billion INR | 11.828% |
| Albert David Limited | 4.97 Billion INR | 31.186% |
| Lupin Limited | 239.97 Billion INR | 98.572% |
| Gufic Biosciences Limited | 10.92 Billion INR | 68.634% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.599% |
| Lincoln Pharmaceuticals Limited | 7 Billion INR | 51.065% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | 15.316% |
| Piramal Enterprises Limited | 826.05 Billion INR | 99.585% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 97.725% |
| NATCO Pharma Limited | 69.06 Billion INR | 95.038% |
| Suven Life Sciences Limited | 2.84 Billion INR | -20.282% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -92.332% |
| Strides Pharma Science Limited | 58.39 Billion INR | 94.132% |
| Indoco Remedies Limited | 21.44 Billion INR | 84.022% |
| Alpa Laboratories Limited | 1.82 Billion INR | -87.649% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -127.143% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 33.464% |